论文部分内容阅读
目的观察小施尔康复合制剂预防小儿及复呼吸道感染的疗效。方法在治疗组应用小施尔康并与对照组口服增强免疫药物左旋咪唑比较观察。结果治疗组的上呼吸道感染次/年和下呼吸道感染次/年明显低于对照组。结论小施尔康复合制剂预防小儿反复呼吸道感染是有效安全药物。
Objective To observe the effect of Xiaoer Er Kang composite in preventing children and complex respiratory infection. Methods In the treatment group, the small Shi Er Kang and the control group oral enhanced immunosuppressive levamisole observation. Results The treatment group had significantly lower frequency of upper respiratory infection and lower respiratory tract infection per year than the control group. Conclusion Xiaoer Er Kang composite preparation for the prevention of recurrent respiratory tract infections in children is an effective and safe drug.